Shein Steven L, Ferguson Nikki M, Kochanek Patrick M, Bayir Hülya, Clark Robert S B, Fink Ericka L, Tyler-Kabara Elizabeth C, Wisniewski Stephen R, Tian Ye, Balasubramani G K, Bell Michael J
1Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. 2Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA. 3Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA. 4Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA.
Pediatr Crit Care Med. 2016 Mar;17(3):236-45. doi: 10.1097/PCC.0000000000000610.
To describe acute cerebral hemodynamic effects of medications commonly used to treat intracranial hypertension in children with traumatic brain injury. Currently, data supporting the efficacy of these medications are insufficient.
In this prospective observational study, intracranial hypertension (intracranial pressure ≥ 20 mm Hg for > 5 min) was treated by clinical protocol. Administration times of medications for intracranial hypertension (fentanyl, 3% hypertonic saline, mannitol, and pentobarbital) were prospectively recorded and synchronized with an automated database that collected intracranial pressure and cerebral perfusion pressure every 5 seconds. Intracranial pressure crises confounded by external stimulation or mechanical ventilator adjustments were excluded. Mean intracranial pressure and cerebral perfusion pressure from epochs following drug administration were compared with baseline values using Kruskal-Wallis analysis of variance and Dunn test. Frailty modeling was used to analyze the time to intracranial pressure crisis resolution. Mixed-effect models compared intracranial pressure and cerebral perfusion pressure 5 minutes after the medication versus baseline and rates of treatment failure.
A tertiary care children's hospital.
Children with severe traumatic brain injury (Glasgow Coma Scale score ≤ 8).
None.
We analyzed 196 doses of fentanyl, hypertonic saline, mannitol, and pentobarbital administered to 16 children (median: 12 doses per patient). Overall, intracranial pressure significantly decreased following the administration of fentanyl, hypertonic saline, and pentobarbital. After controlling for administration of multiple medications, intracranial pressure was decreased following hypertonic saline and pentobarbital administration; cerebral perfusion pressure was decreased following fentanyl and was increased following hypertonic saline administration. After adjusting for significant covariates (including age, Glasgow Coma Scale score, and intracranial pressure), hypertonic saline was associated with a two-fold faster resolution of intracranial hypertension than either fentanyl or pentobarbital. Fentanyl was significantly associated with the most frequent treatment failure.
Intracranial pressure decreased after multiple drug administrations, but hypertonic saline may warrant consideration as the first-line drug for treating intracranial hypertension, as it was associated with the most favorable cerebral hemodynamics and fastest resolution of intracranial hypertension.
描述常用于治疗创伤性脑损伤患儿颅内高压的药物的急性脑血流动力学效应。目前,支持这些药物疗效的数据不足。
在这项前瞻性观察研究中,按照临床方案治疗颅内高压(颅内压≥20 mmHg持续超过5分钟)。前瞻性记录用于治疗颅内高压的药物(芬太尼、3%高渗盐水、甘露醇和戊巴比妥)的给药时间,并与每5秒收集颅内压和脑灌注压的自动数据库同步。排除由外部刺激或机械通气调整引起的颅内压危机。使用Kruskal-Wallis方差分析和Dunn检验将给药后各时段的平均颅内压和脑灌注压与基线值进行比较。采用脆弱性模型分析颅内压危机解决时间。混合效应模型比较了用药后5分钟时的颅内压和脑灌注压与基线值以及治疗失败率。
一家三级儿童专科医院。
重度创伤性脑损伤患儿(格拉斯哥昏迷量表评分≤8分)。
无。
我们分析了给16名儿童使用的196剂芬太尼、高渗盐水、甘露醇和戊巴比妥(中位数:每名患者12剂)。总体而言,芬太尼、高渗盐水和戊巴比妥给药后颅内压显著降低。在控制多种药物给药后,高渗盐水和戊巴比妥给药后颅内压降低;芬太尼给药后脑灌注压降低,高渗盐水给药后脑灌注压升高。在调整显著协变量(包括年龄、格拉斯哥昏迷量表评分和颅内压)后,高渗盐水使颅内高压的缓解速度比芬太尼或戊巴比妥快两倍。芬太尼与最频繁的治疗失败显著相关。
多次给药后颅内压降低,但高渗盐水可能值得作为治疗颅内高压的一线药物考虑,因为它与最有利的脑血流动力学和最快的颅内高压缓解相关。